<h1>23andMe Blood Collection Study</h1>
<p>Genetics testing company 23andMe leveraged its resources to recruit individuals for the 23andMe Blood Collection Study. The company reached out to individuals carrying the LRRK2 G2019S mutation, inviting them to donate a blood sample.</p>
<h3>Accessing Data and Biosamples</h3>
<p>23andMe is currently analyzing its data and samples and will share resources in the near future. Email <a href="mailto:resources@michaeljfox.org" class="orange" target="_top">resources@michaeljfox.org</a> to be notified when the data and samples are available.</p>
<table class="studyDesignTable">
<tbody>
<tr>
<td><strong>Cohort</strong></td>
<td><strong>Blood + Clinical Data</strong></td>
</tr>
<tr>
<td>Idiopathic PD</td>
<td>20</td>
</tr>
<tr>
<td>LRRK2+ PD</td>
<td>52</td>
</tr>
<tr>
<td>LRRK2+ carriers</td>
<td>152</td>
</tr>
<tr>
<td>Controls</td>
<td>18</td>
</tr>
</tbody>
</table>
